# Strides Pharma Science (NSE: STAR) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/STAR · Pivot · prices to 22 Oct 2026

Strides Pharma Science (NSE: STAR) closed at ₹1,017.30 on 22 Oct 2026, down 1.23% on the day. With a market capitalisation of ₹9,377 Cr, it ranks 573rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 16.9× trailing earnings, against a return on equity of 17.9% in FY26. Over the past year the share price has risen 27.8%. Its 52-week range is ₹768.65 (29 Jan 2026) to ₹1,260.90 (21 Sep 2026); the last close is 19.3% below the high. Promoters held 27.91% of the company as of 30 Jun 2026; 38.10% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹1,017.30 |
| Market cap | ₹9,377 Cr |
| P/E (trailing) | 16.9 |
| ROE | 17.9% (FY26) |
| ROCE | 21.7% (FY26) |
| Debt to equity | 0.54 |
| 52-week high | ₹1,260.90 (21 Sep 2026) |
| 52-week low | ₹768.65 (29 Jan 2026) |
| 1-year return | +27.8% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹4,565 Cr | ₹3,596 Cr |
| FY24 | ₹4,051 Cr | ₹81 Cr |
| FY23 | ₹3,688 Cr | ₹73 Cr |
| FY22 | ₹3,070 Cr | −₹363 Cr |
| FY21 | ₹3,316 Cr | ₹356 Cr |
| FY20 | ₹2,752 Cr | ₹138 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 27.91%
- Foreign institutions: 28.39%
- Domestic institutions: 15.41%
- Non-institutions: 28.28%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Akums Drugs and Pharmaceuticals](https://app.pivotnow.in/stock/AKUMS) | ₹690.85 | ₹10,874 Cr | 41.5 | — |
| [Park Medi World](https://app.pivotnow.in/stock/PARKHOSPS) | ₹220.45 | ₹9,522 Cr | 32.1 | — |
| [Blue Jet Healthcare](https://app.pivotnow.in/stock/BLUEJET) | ₹499.60 | ₹9,456 Cr | 35 | — |
| [Viyash Scientific](https://app.pivotnow.in/stock/VIYASH) | ₹214.90 | ₹9,388 Cr | 53.6 | — |
| [Yatharth Hospital & Trauma Care Services](https://app.pivotnow.in/stock/YATHARTH) | ₹932.10 | ₹8,981 Cr | 51.2 | — |
| [Healthcare Global Enterprises](https://app.pivotnow.in/stock/HCG) | ₹552.00 | ₹8,241 Cr | — | — |

## Questions and answers

### What is the share price of Strides Pharma Science today?

Strides Pharma Science (NSE: STAR) last closed at ₹1,017.30 on 22 Oct 2026. Its 52-week high is ₹1,260.90 and its 52-week low is ₹768.65.

### What is the market cap of Strides Pharma Science?

Strides Pharma Science's market capitalisation is ₹9,377 Cr (₹9,377 Cr) at the 22 Oct 2026 close, ranking 573rd among the NSE companies Pivot tracks.

### What is the P/E ratio of Strides Pharma Science?

Strides Pharma Science trades at a trailing P/E of 16.9. The median P/E of the 5 closest Pharma & Healthcare peers by market cap is 41.5.

### What is the ROE and ROCE of Strides Pharma Science?

Return on equity was 17.9% in FY26 and return on capital employed was 21.7% in FY26 (consolidated figures).

### Is Strides Pharma Science a debt-free company?

No. Strides Pharma Science's debt-to-equity ratio was 0.54 in FY26, with total debt of ₹552 Cr.

### How has Strides Pharma Science stock performed over the last year?

Strides Pharma Science's share price has risen 27.8% over the past year, −2.4% over three months and −17.1% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Strides Pharma Science?

As of 30 Jun 2026: promoters 27.91%, foreign institutions 28.39%, domestic institutions 15.41%, non-institutions 28.28%. 38.10% of promoter shares were pledged.

### Who are Strides Pharma Science's competitors?

The listed Pharma & Healthcare companies closest to Strides Pharma Science by market cap are Akums Drugs and Pharmaceuticals, Park Medi World, Blue Jet Healthcare, Viyash Scientific, Yatharth Hospital & Trauma Care Services and Healthcare Global Enterprises.

### Is Strides Pharma Science a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Strides Pharma Science's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on STAR against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.